Information  X 
Enter a valid email address

Wilmington PLC (WIL)

  Print      Mail a friend       Annual reports

Tuesday 09 July, 2019

Wilmington PLC

Director/PDMR Shareholding

RNS Number : 9963E
Wilmington PLC
09 July 2019
 

9 July 2019

 

Wilmington plc

Director/PDMR Shareholding

 

 

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, Wilmington plc (the 'Company') was advised on 8 July 2019 that:

 

·      Richard Amos, Chief Financial Officer, bought 24,250 ordinary shares of 5p each in the Company on 8 July 2019 at an average of 202 pence per share. His resultant holding of ordinary shares of 5p each is 24,250 which represent 0.03% of the issued share capital with voting rights: The shares are registered in the name of his wife Brigid Amos who is the beneficial holder; and

 

·      Martin Morgan, Non-Executive Chairman, bought 25,000 ordinary shares of 5p each in the Company on 8 July 2019 at an average of 200 pence per share. His resultant holding of ordinary shares of 5p each is 50,000 which represent 0.06% of the issued share capital with voting rights.

 

 

 

For further information, please contact:

 

Wilmington plc                                                     020 7490 0049

 

Richard Amos, Company Secretary and Chief Financial Officer

 

FTI Consulting                                                       020 3727 1000

 

Charles Palmer / Dwight Burden / Leah Dudley

 

 

Notes to Editors 

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed Company on the main market of the London Stock Exchange.

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

RICHARD AMOS / BRIGID AMOS

 

2.

Reason for the notification

 

a)

Position /status

CHIEF FINANCIAL OFFICER

 

b)

Initial notification / amendment

 

INITIAL NOTIFICATION

3.

Details of the Issuer

 

a)

Name

WILMINGTON PLC

 

b)

LEI code

 

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES IN WILMINGTON PLC

 

ISIN: GB0009692319

 

b)

Nature of the transaction

PURCHASE OF ORDINARY SHARES

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.02

24,250

 

 

 

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

 

8 JULY 2019

f)

Place of the transaction

 

LONDON

 

 

 

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

Name

MARTIN MORGAN

 

Reason for the notification

 

Position /status

NON-EXECUTIVE CHAIRMAN

 

Initial notification / amendment

 

INITIAL NOTIFICATION

Details of the Issuer

 

Name

WILMINGTON PLC

 

LEI code

 

N/A

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES IN WILMINGTON PLC

 

ISIN: GB0009692319

 

Nature of the transaction

PURCHASE OF ORDINARY SHARES

Price(s) and volume(s)

Price(s)

Volume(s)

2.00

25,000

 

 

 

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

Date of the transaction

 

8 JULY 2019

Place of the transaction

 

LONDON

     

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHRLMATMBIMBRL

a d v e r t i s e m e n t